by PEPID Newsroom | Mar 21, 2019 | Alerts
The FDA approved the Optimizer Smart system for patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac re-synchronization therapy to restore a normal heartbeat timing pattern. The...
by Anna Tan | Mar 20, 2019 | Alerts
FDA Approves Spravato (esketamine) nasal spray to treat treatment-resistant depression in adults, but is only available at certified doctor’s offices and clinics. Treatment-resistant patients are adults with major depressive disorder, who have tried a minimum of two...
by PEPID Newsroom | Mar 14, 2019 | Alerts
The Food and Drug Administration (FDA) has allowed marketing of ClearMate to treat patients suffering from carbon monoxide poisoning in emergency rooms. Malvina Eydelman, M.D., director of the Division of Ophthalmic, and Ear, Nose and Throat Devices in the FDA’s...
by PEPID Newsroom | Mar 6, 2019 | Alerts
Measles, also known as rubeola or “first disease”, is a highly contagious viral infection caused by paramyxovirus, causing a prodrome of fever, cough, coryza, and conjunctivitis followed by eruption of maculopapular rash. The CDC states 2 main reasons for the increase...
